
Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques
Keywords: ایمپلنت; DLS; Dynamic light scattering; DOL; Degree of labeling; FCS; Fetal calf serum; GAPDH; Glyceraldehyde 3-phosphate dehydrogenase; HA; Hyaluronan; IFN; Interferon; i.m.; Intramuscular; ISG; Interferon stimulated gene; IVIVC; In vitro-in vivo-correlation; LN;